These findings identify hsa-miR-AMC1 as a novel miRNA that is up-regulated by CVB4 infection of pancreatic β cells where it further promotes infection and suppresses insulin secretion, suggesting that this miRNA may serve as a novel diagnostic marker and/or therapeutic target for CVB4-induced T1D. Here, INS is linked to infection.